Analgesics - UK

Published by: Mintel International Group Ltd.

Published: Sep. 1, 2008 - 79 Pages

Table of Contents

Issues in the Market

Main report themes

Definition

Market in Brief

Pushing the pain barrier

Splurge or save

Just in case

Looking forward

Internal Market Environment

Key points

An end to suffering?

Figure 1: Selected ailments suffered from in the last 12 months, GB, 2003-07

Tackling specifics

Health benefits…

…but there are limits

A healthy perspective

Figure 2: Attitudes towards health, GB, 2003-07

Own-label options

No pain, no gain

Sales restrictions

Broader Market Environment

Key points

Future potential

Figure 3: Forecast adult population, by socio-economic group, 2003-13

The UK’s greying population

Figure 4: Structure of the UK population, by gender and age, 2003-13

Self-diagnosis and the internet

Competitive Context

Key points

In context

Figure 5: Market value of OTC pharmaceuticals, 2003-07

Cold and flu remedies

Complementary medicines

Prescriptions

Non-treatment

Strengths and Weaknesses in the Market

Strengths

Weaknesses

Market Size and Forecast

Key points

On the up

Figure 7: UK retail value sales of analgesics, at current and constant prices, 2003-13

The best things come in small packages

Figure 8: Volume and unit sales of oral analgesics, 2003-13

Figure 9: Average spend on analgesics per user and average pills per user*, 2003-07

The future

Factors used in the forecast

Segment Performance

Key points

Active ingredient

Figure 10: UK retail sales of analgesics, by active ingredient, 2006-08

Ibuprofen

Paracetamol

Aspirin

Paediatric formulations

Paracetamol and codeine

Ibuprofen and codeine

Paracetamol and aspirin

Other

Format

Figure 11: UK retail value sales of analgesics, by product format, 2006-08

Tablets and caplets

Capsules

Paediatric formulations

Soluble tablets

Topical formulations

Market Share

Key points

Nurofen leads the pack

Figure 12: Brand shares in the UK analgesics market, 2006-08

Own-label encroaches

Companies and Products

Reckitt Benckiser

Nurofen

Disprin

Disprol

GlaxoSmithKline

Imigran Recovery

Solpadeine

Panadol

Hedex

Wyeth Consumer Healthcare

Anadin

Johnson & Johnson

Calpol

SSL International

Syndol/Cuprofen/Medinol/Paramol

Bayer

Feminax

Aspro/Paracodol/Askit

Own-label

Brand Communication and Promotion

Key points

A downwards spiral

Figure 13: Main monitored media advertising expenditure on OTC analgesics, 2003-08

Reckitt on top

Figure 14: Main monitored media advertising expenditure on OTC analgesics, by top 15 advertisers, 2003-07

Figure 15: Share of adspend vs market share, by brand, 2007

Advertising strategies

Strength and speed

In the know

Below the line

Channels to Market

Key points

Multiples multiply

Figure 16: UK retail value sales of analgesics, by outlet type, 2006-08

Others

The Consumer - Usage Frequency and Format

Key points

Usage

The pain subsides

Figure 17: Usage of headache remedies and rubs & rheumatism remedies in the last 12 months, 2003-07

Women seek relief in old age

Younger women sit in the middle

Adopting a light touch

Format

Youngsters pop pills

Figure 18: Format of OTC analgesics used in the last 12 months by self or family, February 2008

A family affair

Drinking it all in

A wealth of topics

The Consumer - Usage Behaviour

Key points

Close to hand

Figure 19: Consumer usage of OTC analgesics, February 2008

If I must

Appendix

Advertising data

Abbreviations

Appendix: Internal Market Environment

Figure 25: Sports participation, regularly and occasionally, 2003-07

Appendix: The Consumer - Usage Frequency and Format

Usage frequency

Figure 26: Usage of headache remedies, by demographic sub-group, 2007

Figure 27: Usage of rubs & rheumatism remedies, by demographic sub-group, 2007

Figure 28: Headache remedies and analgesics usage, by complaint suffered, 2007

Figure 29: Headache remedies and analgesics usage, by attitudes towards health, 2007

Format

Figure 30: Format of OTC analgesics used in the last 12 months by self or family, by demographic sub-group, February 2008

Appendix: The Consumer - Usage Behaviour

Figure 31: Consumer behaviour usage of OTC analgesics, by demographic sub-groups, February 2008

Abstract

This report looks at how the analgesics market has evolved since Mintel last looked at it in September 2006. Over the last two years, the market has grown strongly propelled by consumers trading up to maximum-strength, fast-acting products and premium liquid capsules. However, the number of consumers opting for cheaper retailer own-label products is also growing as they become more informed about what active ingredients their preferred pain relief contains.

Main report themes

• Competition between own-label and manufacturer brands.
• Concerns over the side effects of using analgesics.
• Growing competition from natural and topical products.
• NPD driven by fast-acting, strong, easy-to-swallow formats.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.